Outlook Therapeutics Total Assets

Outlook Therapeutics (OTLK) currently reports a total assets of $22T as of March 2026. That compares with $19T in the prior-year period — up 14.8% year over year. Use the charts on this page to explore Outlook Therapeutics's total assets history and peer comparisons.

Outlook Therapeutics's total assets increased from $19T to $22T — a 14.8% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Outlook Therapeutics reported $22T in total assets as of March 2026. That compares with $19T in the prior-year period — up 14.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $22T, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Outlook Therapeutics, and consider following OTLK for alerts when major investors trade the stock.

Outlook Therapeutics is classified in the Healthcare sector. On total assets, it currently shows $22T. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OTLK with unrelated industries.